TürkiyeResearch and clinical trials
First national count using Ministry e-health data: 406 patients with congenital myasthenic syndrome in Türkiye
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
The Ministry of Health's e-health records from 2015–2024 were searched. A total of 406 patients diagnosed with congenital myasthenic syndrome were found. 58.6% of patients had been diagnosed before age 18. In 2023, the prevalence was calculated as 4.49 per million. 68.2% of patients had been prescribed pyridostigmine at least once.
What does it mean for patients and families?
This shows the frequency of the disease in Türkiye using national data for the first time. The figures are based on diagnosis codes, so patients who have not been diagnosed may not be counted.
Source
Scientific paper: Epidemiological study of congenital myasthenic syndromes based on national electronic health database of Turkiye. Northern Clinics of Istanbul, 2025. DOI: 10.14744/nci.2025.08455 · PubMed 41059415
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Congenital myasthenic syndromes (CMS)
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.